Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 9, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	940,055	176,537	-	-	-
Enterprise Value	895,086	152,373	-	-	-
Last Close Price	21150.00	16340.00	-	-	-
PS Ratio	31.95	11.90	-	-	-
PB Ratio	15.94	3.15	-	-	-
P/TBV Ratio	15.94	3.15	-	-	-
EV/Sales Ratio	30.42	10.27	-	-	-
Debt / Equity Ratio	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.10	-	0.13	-	-
Debt / FCF Ratio	-	-	0.12	-	-
Asset Turnover	0.59	0.30	0.62	0.00	-
Quick Ratio	11.84	10.61	0.71	1.06	36.08
Current Ratio	12.10	10.94	0.71	1.06	36.10
Return on Equity (ROE)	9.95%	-32.29%	-	-	-
Return on Assets (ROA)	2.15%	-6.09%	4.07%	-36.85%	-
Return on Capital (ROIC)	2.31%	-11.81%	-	-	-
Earnings Yield	0.49%	-4.58%	-	-	-
FCF Yield	-0.45%	-4.52%	-	-	-
Buyback Yield / Dilution	-778.57%	-1314.60%	90.00%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.